Repligen (RGEN) Common Equity (2010 - 2026)
Repligen's Common Equity was $2.11 billion in Q2 2026, up 2.4% from $2.06 billion a year earlier and up 0.3% from the prior quarter.
Powered by 
Analysis
Repligen (RGEN) Common Equity (2010 - 2026) Analysis & Trends
From Q4 2011 onward, Repligen has reported Common Equity for 58 quarters.
- Common Equity has now increased for 12 consecutive years, with a five-year compound annual growth rate of 6.6% (FY2020 to FY2025).
- In earlier years, Common Equity was $1.97 billion in FY2024 (+0.4%), $1.96 billion in FY2023 (+2.8%), $1.91 billion in FY2022 (+9.2%) and $1.75 billion in FY2021 (+14.4%).
- The Q2 2026 figure marks the highest quarterly Common Equity in data going back to Q4 2011.
- Compared with a year earlier, Common Equity has increased for 50 straight quarters, with growth averaging 3.3% over the last eight quarters.
- Across the past five years, year-over-year growth in Common Equity ran from 0.4% in Q4 2024 to 52.5% in Q3 2021.
- Per Business Quant data, RGEN's Common Equity in the three quarters before Q2 2026 was $2.11 billion (Q1 2026), $2.11 billion (Q4 2025) and $2.08 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 249.71 Bn | 228.86 Bn | 4.88 Bn | 52.69 Bn |
| 2 | Abbott Laboratories | 171.00 Bn | 142.08 Bn | 7.27 Bn | 51.76 Bn |
| 3 | Danaher | 155.79 Bn | 139.61 Bn | 3.61 Bn | 52.59 Bn |
| 4 | Intuitive Surgical | 143.91 Bn | 123.46 Bn | 1.96 Bn | 18.30 Bn |
| 5 | Medtronic | 110.42 Bn | 76.29 Bn | 6.34 Bn | 50.85 Bn |
| 6 | Stryker | 105.71 Bn | 91.82 Bn | 4.50 Bn | 23.99 Bn |
| 7 | Boston Scientific | 63.26 Bn | 58.27 Bn | 3.85 Bn | 25.17 Bn |
| 8 | Edwards Lifesciences | 49.80 Bn | 33.91 Bn | 1.35 Bn | 10.72 Bn |
| 9 | Becton Dickinson | 48.78 Bn | 45.93 Bn | 2.32 Bn | 24.42 Bn |
| 10 | Repligen | 10.85 Bn | 7.74 Bn | 110.04 Mn | 2.11 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.11 Bn |
| Mar 31, 2026 | 2.11 Bn |
| Dec 31, 2025 | 2.11 Bn |
| Sep 30, 2025 | 2.08 Bn |
| Jun 30, 2025 | 2.06 Bn |
| Mar 31, 2025 | 1.99 Bn |
| Dec 31, 2024 | 1.97 Bn |
| Sep 30, 2024 | 2.02 Bn |
| Jun 30, 2024 | 1.98 Bn |
| Mar 31, 2024 | 1.97 Bn |
| Dec 31, 2023 | 1.96 Bn |
| Sep 30, 2023 | 1.97 Bn |
| Jun 30, 2023 | 1.96 Bn |
| Mar 31, 2023 | 1.93 Bn |
| Dec 31, 2022 | 1.91 Bn |
| Sep 30, 2022 | 1.84 Bn |
| Jun 30, 2022 | 1.81 Bn |
| Mar 31, 2022 | 1.77 Bn |
| Dec 31, 2021 | 1.75 Bn |
| Sep 30, 2021 | 1.72 Bn |
API Access
Repligen Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=RGEN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "RGEN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=RGEN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();